{"disease":{"id":"kidney-transplant","name":"kidney transplant"},"drugs":{"marketed":[{"drug_id":"ciclosporin","indication_name":"Prevention of Kidney Transplant Rejection","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Sandimmune","generic_name":"Ciclosporin","company_name":"Novartis","drug_phase":"marketed","molecular_target":"Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform","drug_class":"Calcineurin Inhibitor Immunosuppressant [EPC]","quality_score":68,"revenue":"1866.0","mechanism":""},{"drug_id":"cyclosporine","indication_name":"Prevention of Kidney Transplant Rejection","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Sandimmune","generic_name":"cyclosporine","company_name":"Novartis AG (originally Sandoz)","drug_phase":"marketed","molecular_target":"Calcineurin subunit B type 1, Canalicular multispecific organic anion transporter 1, Canalicular multispecific organic anion transporter 2","drug_class":"Calcineurin inhibitor (immunosuppressant)","quality_score":67,"revenue":"1866.0","mechanism":"Calcineurin inhibitor that suppresses T-cell activation by blocking IL-2 transcription, preventing organ transplant rejection."},{"drug_id":"tacrolimus","indication_name":"Prevention of Kidney Transplant Rejection","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Prograf","generic_name":"TACROLIMUS","company_name":"Astellas Pharma","drug_phase":"marketed","molecular_target":"Interferon gamma","drug_class":"Calcineurin Inhibitor Immunosuppressant","quality_score":80,"revenue":"1600","mechanism":"Prograf works by inhibiting the activation of T-lymphocytes, a type of immune cell."},{"drug_id":"everolimus","indication_name":"Prevention of Kidney Transplant Rejection","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Afinitor","generic_name":"everolimus","company_name":"Novartis","drug_phase":"marketed","molecular_target":"Serine/threonine-protein kinase mTOR","drug_class":"Kinase Inhibitor [EPC]","quality_score":67,"revenue":"600","mechanism":"Afinitor works by blocking the mTOR protein, which is involved in cell growth and division."},{"drug_id":"afinitor","indication_name":"Prevention of Kidney Transplant Rejection","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Afinitor","company_name":"Central European Society for Anticancer Drug Research","drug_phase":"marketed","molecular_target":"Multidrug resistance protein 1, Peptidyl-prolyl cis-trans isomerase FKBP1A, Serine/threonine-protein kinase mTOR","drug_class":"","quality_score":19,"revenue":null,"mechanism":null},{"drug_id":"ciclosporine","indication_name":"Prevention of Kidney Transplant Rejection","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"ciclosporine","company_name":"Hospices Civils de Lyon","drug_phase":"phase_3","molecular_target":"Calcineurin subunit B type 1, Canalicular multispecific organic anion transporter 1, Canalicular multispecific organic anion transporter 2","drug_class":"","quality_score":35,"revenue":null,"mechanism":null},{"drug_id":"mycophenolate-mofetil","indication_name":"Prevention of Kidney Transplant Rejection","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Cellcept","generic_name":"MYCOPHENOLATE MOFETIL","company_name":"Roche Palo","drug_phase":"marketed","molecular_target":"Inosine-5'-monophosphate dehydrogenase 2","drug_class":"Antimetabolite Immunosuppressant","quality_score":10,"revenue":null,"mechanism":"Cellcept works by inhibiting the enzyme inosine-5'-monophosphate dehydrogenase 2, which is necessary for the production of guanosine nucleotides."},{"drug_id":"valganciclovir","indication_name":"Prevention of CMV Disease After Kidney Transplantation","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Valcyte","generic_name":"VALGANCICLOVIR","company_name":"Cheplapharm","drug_phase":"marketed","molecular_target":"","drug_class":"Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor","quality_score":70,"revenue":null,"mechanism":"Valcyte works by inhibiting the replication of cytomegalovirus DNA through its action as a nucleoside analog DNA polymerase inhibitor."},{"drug_id":"valganciclovir","indication_name":"Prevention of CMV Disease After Kidney-Pancreas Transplantation","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Valcyte","generic_name":"VALGANCICLOVIR","company_name":"Cheplapharm","drug_phase":"marketed","molecular_target":"","drug_class":"Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor","quality_score":70,"revenue":null,"mechanism":"Valcyte works by inhibiting the replication of cytomegalovirus DNA through its action as a nucleoside analog DNA polymerase inhibitor."},{"drug_id":"mycophenolic-acid","indication_name":"Prevention of Kidney Transplant Rejection","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Mycophenolate","generic_name":"MYCOPHENOLIC ACID","company_name":"Novartis","drug_phase":"marketed","molecular_target":"Inosine-5'-monophosphate dehydrogenase 2","drug_class":"Antimetabolite Immunosuppressant","quality_score":10,"revenue":null,"mechanism":""},{"drug_id":"ganciclovir","indication_name":"Prevention of CMV Disease After Kidney Transplantation","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Cytovene","generic_name":"GANCICLOVIR","company_name":"Roche Palo","drug_phase":"marketed","molecular_target":"Metabotropic glutamate receptor 1","drug_class":"Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor","quality_score":80,"revenue":null,"mechanism":"GANCICLOVIR works by inhibiting the DNA polymerase enzyme of cytomegalovirus, preventing viral replication."},{"drug_id":"ganciclovir","indication_name":"Prevention of CMV Disease After Kidney-Pancreas Transplantation","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Cytovene","generic_name":"GANCICLOVIR","company_name":"Roche Palo","drug_phase":"marketed","molecular_target":"Metabotropic glutamate receptor 1","drug_class":"Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor","quality_score":80,"revenue":null,"mechanism":"GANCICLOVIR works by inhibiting the DNA polymerase enzyme of cytomegalovirus, preventing viral replication."},{"drug_id":"sirolimus","indication_name":"Prevention of Kidney Transplant Rejection","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Rapamune","generic_name":"sirolimus","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Serine/threonine-protein kinase mTOR","drug_class":"mTOR Inhibitor Immunosuppressant [EPC]","quality_score":80,"revenue":null,"mechanism":"Rapamune works by binding to the mTOR protein, inhibiting its activity and preventing the growth and proliferation of certain cells."},{"drug_id":"neoral","indication_name":"Prevention of Kidney Transplant Rejection","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Neoral","company_name":"Novartis Pharmaceuticals","drug_phase":"marketed","molecular_target":"Calcineurin subunit B type 1, Canalicular multispecific organic anion transporter 1, Canalicular multispecific organic anion transporter 2","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"cyclosporin","indication_name":"Prevention of Kidney Transplant Rejection","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Cyclosporin","company_name":"Karolinska University Hospital","drug_phase":"marketed","molecular_target":"Calcineurin subunit B type 1, Canalicular multispecific organic anion transporter 1, Canalicular multispecific organic anion transporter 2","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"anti-thymocyte-globulin","indication_name":"Prophylaxis and treatment of acute rejection in kidney transplant","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Anti Thymocyte Globulin","company_name":"Novartis Pharmaceuticals","drug_phase":"marketed","molecular_target":"","drug_class":"Immunoglobulin G [EPC]","quality_score":15,"revenue":null,"mechanism":null},{"drug_id":"rapamycin","indication_name":"Prevention of Kidney Transplant Rejection","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Rapamycin","company_name":"Institut National de la Santé Et de la Recherche Médicale, France","drug_phase":"marketed","molecular_target":"Peptidyl-prolyl cis-trans isomerase FKBP3, Sodium/nucleoside cotransporter 1, ATP-binding cassette sub-family G member 2","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"rapamune","indication_name":"Prevention of Kidney Transplant Rejection","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Rapamune","company_name":"Wyeth is now a wholly owned subsidiary of Pfizer","drug_phase":"marketed","molecular_target":"Peptidyl-prolyl cis-trans isomerase FKBP3, Sodium/nucleoside cotransporter 1, ATP-binding cassette sub-family G member 2","drug_class":"","quality_score":19,"revenue":null,"mechanism":null},{"drug_id":"azathioprine","indication_name":"Prevention of Kidney Transplant Rejection","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Imuran","generic_name":"AZATHIOPRINE","company_name":"Legacy Pharma","drug_phase":"marketed","molecular_target":"ATP-binding cassette sub-family G member 2","drug_class":"Purine Antimetabolite [EPC]","quality_score":55,"revenue":null,"mechanism":""},{"drug_id":"mycophenolate","indication_name":"Prevention of Kidney Transplant Rejection","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Mycophenolate","company_name":"Sanofi","drug_phase":"marketed","molecular_target":"Inosine-5'-monophosphate dehydrogenase 1, Inosine-5'-monophosphate dehydrogenase 2, Inosine-5'-monophosphate dehydrogenase (IMPDH)","drug_class":"","quality_score":42,"revenue":null,"mechanism":null}],"pipeline":[],"offLabel":[],"totalMarketed":20,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03723668","title":"Kidney Transplant Outcome and Organ Acceptance Practice Pattern: A Nationwide Analyses in the US and France","phase":"","overall_status":"COMPLETED","enrollment_count":94017,"lead_sponsor_name":"Paris Translational Research Center for Organ Transplantation","has_results":false},{"nct_id":"NCT05497518","title":"The KidneyCARE (Community Access to Research Equity) Study","phase":"","overall_status":"RECRUITING","enrollment_count":50000,"lead_sponsor_name":"Tufts Medical Center","has_results":false},{"nct_id":"NCT04258891","title":"Multidimensional System to Dynamically Predict Graft Survival After Kidney Transplantation","phase":"","overall_status":"COMPLETED","enrollment_count":14000,"lead_sponsor_name":"Paris Translational Research Center for Organ Transplantation","has_results":false},{"nct_id":"NCT04759209","title":"Development and Validation of a Virtual Biopsy System in Kidney Transplant","phase":"","overall_status":"UNKNOWN","enrollment_count":12992,"lead_sponsor_name":"Paris Translational Research Center for Organ Transplantation","has_results":false},{"nct_id":"NCT06348446","title":"Tacrolimus Exposure in Kidney Transplantation","phase":"","overall_status":"UNKNOWN","enrollment_count":12000,"lead_sponsor_name":"Seoul National University Hospital","has_results":false},{"nct_id":"NCT05229939","title":"Estimating Glomerular Filtration Rate in Kidney Transplant Recipients","phase":"","overall_status":"COMPLETED","enrollment_count":11412,"lead_sponsor_name":"Paris Translational Research Center for Organ Transplantation","has_results":false},{"nct_id":"NCT06416761","title":"Genetics in the Progression of Nephropathies","phase":"","overall_status":"RECRUITING","enrollment_count":10000,"lead_sponsor_name":"Ospedale San Raffaele","has_results":false},{"nct_id":"NCT06496269","title":"Impact of Microvascular Inflammation on Kidney Allograft Outcome","phase":"","overall_status":"COMPLETED","enrollment_count":6000,"lead_sponsor_name":"Paris Translational Research Center for Organ Transplantation","has_results":false},{"nct_id":"NCT07269275","title":"HLA Eplet Mismatches to Predict Long-term Kidney Transplant Outcomes","phase":"","overall_status":"COMPLETED","enrollment_count":5525,"lead_sponsor_name":"Paris Translational Research Center for Organ Transplantation","has_results":false},{"nct_id":"NCT06436586","title":"Impact of HLA Evolutionary Divergence and HLA Donor-recipient Molecular Mismatches on Kidney Allograft Rejection","phase":"","overall_status":"COMPLETED","enrollment_count":5159,"lead_sponsor_name":"Paris Translational Research Center for Organ Transplantation","has_results":false},{"nct_id":"NCT05318196","title":"Molecular Prediction of Development, Progression or Complications of Kidney, Immune or Transplantation-related Diseases","phase":"","overall_status":"RECRUITING","enrollment_count":5000,"lead_sponsor_name":"University Hospital, Toulouse","has_results":false},{"nct_id":"NCT04091984","title":"The PROspera Kidney Transplant ACTIVE Rejection Assessment Registry (ProActive)","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":5000,"lead_sponsor_name":"Natera, Inc.","has_results":false},{"nct_id":"NCT01670058","title":"Pattern Of Use Of Belatacept In US Transplant Recipients","phase":"","overall_status":"COMPLETED","enrollment_count":5000,"lead_sponsor_name":"Bristol-Myers Squibb","has_results":false},{"nct_id":"NCT07078578","title":"A Predictive Model for Postoperative Delirium in Kidney Transplant Patients","phase":"","overall_status":"COMPLETED","enrollment_count":4800,"lead_sponsor_name":"Hua Zheng","has_results":false},{"nct_id":"NCT02555787","title":"Global, Multicentre, Non Interventional Advagraf Conversion Registry in Kidney Transplant Patients","phase":"","overall_status":"COMPLETED","enrollment_count":4430,"lead_sponsor_name":"Astellas Pharma Europe Ltd.","has_results":false},{"nct_id":"NCT04810884","title":"Fractures and Bone Disease in Living Kidney Donors","phase":"","overall_status":"COMPLETED","enrollment_count":4415,"lead_sponsor_name":"Mayo Clinic","has_results":false},{"nct_id":"NCT06394596","title":"Predicting Prognostic Factors in Kidney Transplantation Using A Machine Learning","phase":"","overall_status":"COMPLETED","enrollment_count":4077,"lead_sponsor_name":"Sung Shin","has_results":false},{"nct_id":"NCT05306795","title":"Development and Validation of a Comprehensive Classification Automation System for Kidney Allograft Biopsies","phase":"","overall_status":"UNKNOWN","enrollment_count":4000,"lead_sponsor_name":"Paris Translational Research Center for Organ Transplantation","has_results":false},{"nct_id":"NCT03326076","title":"Evaluation of Patient Outcomes From the Kidney Allograft Outcomes AlloSure Registry","phase":"","overall_status":"UNKNOWN","enrollment_count":4000,"lead_sponsor_name":"CareDx","has_results":false},{"nct_id":"NCT03674307","title":"Screening for Asymptomatic Coronary Artery Disease in Kidney Transplant Candidates","phase":"NA","overall_status":"RECRUITING","enrollment_count":3306,"lead_sponsor_name":"University of British Columbia","has_results":false},{"nct_id":"NCT07208994","title":"Pathways to Equitable Access to Kidney Transplantation in Spain: A Transformative Mixed-methods Study Protocol","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":3000,"lead_sponsor_name":"Hospital del Mar","has_results":false},{"nct_id":"NCT05995379","title":"Donor Derived Cell-free DNA and Rejection of Kidney Allografts","phase":"","overall_status":"COMPLETED","enrollment_count":2500,"lead_sponsor_name":"Paris Translational Research Center for Organ Transplantation","has_results":false},{"nct_id":"NCT06116721","title":"Evaluation of APOL1 Gene Variants in Kidney Donors and Their Impact on Long-term Renal Function in Donors and Recipients","phase":"","overall_status":"UNKNOWN","enrollment_count":2450,"lead_sponsor_name":"Hospital do Rim e Hipertensão","has_results":false},{"nct_id":"NCT02057484","title":"A 5 Year Follow-up of Patients Who Were Previously Enrolled Into an Advagraf Trial Following a Liver or Kidney Transplant","phase":"","overall_status":"COMPLETED","enrollment_count":2300,"lead_sponsor_name":"Astellas Pharma Europe Ltd.","has_results":false},{"nct_id":"NCT05945511","title":"Silent Gallbladder Stone in Kidney Transplantation Recipients: Should it be Treated?","phase":"","overall_status":"COMPLETED","enrollment_count":2295,"lead_sponsor_name":"Seoul National University Hospital","has_results":false},{"nct_id":"NCT01950819","title":"Advancing Renal TRANSplant eFficacy and Safety Outcomes With an eveRolimus-based regiMen (TRANSFORM)","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":2037,"lead_sponsor_name":"Novartis Pharmaceuticals","has_results":true},{"nct_id":"NCT06148116","title":"Attitudes and Knowledge of Dialysis Patients Towards Kidney Transplantation","phase":"","overall_status":"UNKNOWN","enrollment_count":2000,"lead_sponsor_name":"Andrzej Frycz Modrzewski Krakow University","has_results":false},{"nct_id":"NCT06505200","title":"Observational Cohort Study Renal Transplantation University Hospitals Leuven","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":1891,"lead_sponsor_name":"Universitaire Ziekenhuizen KU Leuven","has_results":false},{"nct_id":"NCT03466775","title":"Anti-Angiotensin II Type 1 Receptor Antibodies and Kidney Transplant Outcomes","phase":"","overall_status":"COMPLETED","enrollment_count":1845,"lead_sponsor_name":"Paris Translational Research Center for Organ Transplantation","has_results":false},{"nct_id":"NCT07436338","title":"ABO- or HLA- Incompatible LDKT Compared to Waitlist/DDKT in Elderly Patients","phase":"","overall_status":"COMPLETED","enrollment_count":1819,"lead_sponsor_name":"Seoul National University Hospital","has_results":false},{"nct_id":"NCT01280708","title":"Protocol DIVAT-Uro","phase":"","overall_status":"TERMINATED","enrollment_count":1616,"lead_sponsor_name":"Nantes University Hospital","has_results":false},{"nct_id":"NCT05679024","title":"Stroke Prophylaxis With Apixaban in Chronic Kidney Disease Stage 5 Patients With Atrial Fibrillation","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":1400,"lead_sponsor_name":"Region Stockholm","has_results":false},{"nct_id":"NCT06512831","title":"Isoniazid Prophylaxis Based on Risk Factors of Tuberculosis in Living Kidney Transplantation Recipients","phase":"NA","overall_status":"COMPLETED","enrollment_count":1348,"lead_sponsor_name":"West China Hospital","has_results":false},{"nct_id":"NCT06016283","title":"Sex Impact on Long-term Outcomes of LDKT","phase":"","overall_status":"COMPLETED","enrollment_count":1276,"lead_sponsor_name":"Erasmus Medical Center","has_results":false},{"nct_id":"NCT00717470","title":"A Study in Kidney Transplant Subjects to Investigate the Optimal Suppression of Immunity to Help Prevent Kidney Rejection","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":1252,"lead_sponsor_name":"Astellas Pharma Inc","has_results":false},{"nct_id":"NCT03468478","title":"Comparison of the Efficacy and Safety of Sirolimus Versus Everolimus Versus Mycophenolate in Kidney Transplantation","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":1209,"lead_sponsor_name":"Hospital do Rim e Hipertensão","has_results":true},{"nct_id":"NCT01304836","title":"A Study Looking at Diabetes in Kidney Transplant Recipients Receiving Immunosuppressive Regimen With or Without Steroids","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":1166,"lead_sponsor_name":"Astellas Pharma Inc","has_results":false},{"nct_id":"NCT06810258","title":"BIOmarkers Before and After Kidney Transplantation","phase":"","overall_status":"RECRUITING","enrollment_count":1000,"lead_sponsor_name":"Assistance Publique - Hôpitaux de Paris","has_results":false},{"nct_id":"NCT06104696","title":"Comprehensive Geriatric Assessment in Kidney Transplantation","phase":"","overall_status":"RECRUITING","enrollment_count":1000,"lead_sponsor_name":"Institute for Clinical and Experimental Medicine","has_results":false},{"nct_id":"NCT03487861","title":"Urinary Transglutaminase 2 as a Biomarker for Kidney Allograft Fibrosis","phase":"","overall_status":"UNKNOWN","enrollment_count":1000,"lead_sponsor_name":"Asan Medical Center","has_results":false},{"nct_id":"NCT03818698","title":"Study of Eplets Matching in Kidney Transplantation","phase":"","overall_status":"UNKNOWN","enrollment_count":1000,"lead_sponsor_name":"First Affiliated Hospital Xi'an Jiaotong University","has_results":false},{"nct_id":"NCT06365411","title":"GEnomic Medicine in Kidney Transplantation Study","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":1000,"lead_sponsor_name":"Western Sydney Local Health District","has_results":false},{"nct_id":"NCT06216795","title":"Kidney Volume in Live Donors Kidney Transplant Donors and Recipients","phase":"","overall_status":"UNKNOWN","enrollment_count":1000,"lead_sponsor_name":"Seoul National University Hospital","has_results":false},{"nct_id":"NCT04566055","title":"Assessing AlloSure Dd-cfDNA Monitoring Insights of Renal Allografts With Longitudinal Surveillance","phase":"","overall_status":"UNKNOWN","enrollment_count":1000,"lead_sponsor_name":"CareDx","has_results":false},{"nct_id":"NCT07333495","title":"A Mixed Cohort, Multicentre Exploratory Study of Non-invasive Quantitative Assessment of Renal Graft Function With Non-contrast Functional Magnetic Resonance Imaging","phase":"","overall_status":"RECRUITING","enrollment_count":1000,"lead_sponsor_name":"Tongji Hospital","has_results":false},{"nct_id":"NCT05715853","title":"Prospective Assessment of Rejection in Kidney Transplant (PARK)","phase":"","overall_status":"UNKNOWN","enrollment_count":1000,"lead_sponsor_name":"NephroSant","has_results":false},{"nct_id":"NCT06087003","title":"Pediatric Induction Therapy in Kidney Transplantation","phase":"","overall_status":"COMPLETED","enrollment_count":958,"lead_sponsor_name":"Gang Chen","has_results":false},{"nct_id":"NCT02392312","title":"Observational Study to Evaluate the Safety and Efficacy of ATG-F on Kidney Transplant Recipients","phase":"","overall_status":"COMPLETED","enrollment_count":950,"lead_sponsor_name":"Astellas Pharma China, Inc.","has_results":false},{"nct_id":"NCT02182986","title":"Biomarkers for Post-Transplant Lymphoproliferative Disorders in Children","phase":"","overall_status":"COMPLETED","enrollment_count":944,"lead_sponsor_name":"National Institute of Allergy and Infectious Diseases (NIAID)","has_results":false},{"nct_id":"NCT01386359","title":"Evaluating Nulojix (Belatacept) Long-Term Safety in Transplant","phase":"","overall_status":"COMPLETED","enrollment_count":914,"lead_sponsor_name":"Bristol-Myers Squibb","has_results":false}],"total":50},"guidelines":[],"source":"Drug Landscape verified database"}